Latest News about TBPH

Recent news which mentions TBPH

< Previous 1 2 3 Next >

Tiziana Life Sciences Has Only Fully Human Anti-CD3 mAB In Clinical Studies, Could Be Poised To Improve Care For Patients With Severe Multiple Sclerosis

April 19, 2023

Theravance Biopharma Finally Shelves Failed JAK Inhibitor Program, Lays Off Staff

February 28, 2023

Earnings Scheduled For February 27, 2023

February 27, 2023

Earnings Preview: Theravance Biopharma

February 24, 2023

Target To Rally 29%? Plus This Analyst Predicts $245 For IQVIA Holdings

November 17, 2022

Earnings Scheduled For November 7, 2022

November 07, 2022

A Preview Of Theravance Biopharma's Earnings

November 04, 2022

Here's Why Theravance Biopharma Shares Are Moving

September 19, 2022

Theravance Outlines $250M Capital Return Program; To Repurchase GSK's Entire Holdings

September 19, 2022

Looking Into Theravance Biopharma's Return On Capital Employed

August 24, 2022

Theravance Biopharma's Earnings: A Preview

August 03, 2022

Why Is Conagra Brands Dropping By More Than 8%? 43 Stocks Moving In Thursday's Mid-Day Session

July 14, 2022

The Daily Biotech Pulse: Much Awaited FDA Nod For Novavax's COVID-19 Shot, DSMB Suggests ContraFect To Stop Antimicrobial-Resistant Infection Study, CytomX Restructures

July 14, 2022

12 Health Care Stocks Moving In Thursday's Pre-Market Session

July 14, 2022

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday

July 14, 2022

Why Is Ericsson Down By 9%? 22 Stocks Moving In Thursday's Pre-Market Session

July 14, 2022

12 Health Care Stocks Moving In Wednesday's After-Market Session

July 13, 2022

Theravance Biopharma, Innoviva Gain On Selling TRELEGY ELLIPTA Royalty Interests

July 13, 2022

Benzinga's Top Ratings Upgrades, Downgrades For May 23, 2022

May 23, 2022

The Daily Biotech Pulse: AstraZeneca's 3 Product Updates, Jazz Pharma Licenses Sleeping Disorder Product, Argenx Aces Bleeding Disorder Study

May 05, 2022

Theravance Biopharma's Earnings Outlook

May 04, 2022

Theravance Biopharma's Ampreloxetine Shows Benefit In Atrophy Patients, But Not In Parkinson's

April 05, 2022

The Daily Biotech Pulse: Thervance Gains On Positive Late-Stage Readout, Bristol-Myers Squibb Snags 3 Approvals In Europe, Decision Day For BioXcel

April 05, 2022

Why Theravance Biopharma Stock Is Trading Lower After Hours

April 04, 2022

Recap: Theravance Biopharma Q4 Earnings

February 24, 2022

12 Health Care Stocks Moving In Wednesday's After-Market Session

February 23, 2022

Earnings Scheduled For February 23, 2022

February 23, 2022

50 Biggest Movers From Yesterday

January 13, 2022

12 Health Care Stocks Moving In Wednesday's Intraday Session

January 12, 2022

28 Stocks Moving In Wednesday's Mid-Day Session

January 12, 2022

< Previous 1 2 3 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

© 2025 FinancialContent. All rights reserved.